Global Drug Addiction Partnering Deals and Agreements Directory 2018 Print E-mail
By PR Newswire:   
Wednesday, 14 March 2018 14:30

The Global Drug Addiction Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and

commercialization of technologies and

Error. Page cannot be displayed. Please contact your service provider for more details. (14)

products in the therapy area.

Key Topics Covered:

Executive Summary

Chapter 1 - Therapy Partnering trends in numbers

Partnering in numbers - by year

Partnering in numbers - most active

Partnering in numbers - by industry sector

Partnering in numbers - by deal type

Partnering in numbers - by technology type

Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

Partnering deals directory - by company A-Z

Partnering deals directory - by deal value

Partnering deals directory - by industry sector

Partnering deals directory - by deal type

Partnering deals directory - by stage of development

Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

Chapter 5 - M&A in numbers

M&A in numbers - by year

Chapter 6 - M&A deals directory

M&A deals directory - by company A-Z

M&A deals directory - by deal value

Chapter 7 - Financing in numbers

Financing in numbers - by year

Financing in numbers - by financing type

Chapter 8 - Financing deals directory

For more information about this report visit

https://www.researchandmarkets.com/research/8hrqdv/global_drug?w=5

Media Contact:

Research and

Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

View original content:http://www.prnewswire.com/news-releases/global-drug-addiction-partnering-deals-and-agreements-directory-2018-300614024.html

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Read more https://www.prnewswire.com/news-releases/global-drug-addiction-partnering-deals-and-agreements-directory-2018-300614024.html




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BioMedReports #Arbutus’ LNP Licensee #Alnylam Announces #FDA Approval of ONPATTRO™ (patisiran), for the Treatment of ATTR Amyloid… https://t.co/SuVNz1uM3i
BioMedReports Why CTI BioPharma Corp. Crashed Today https://t.co/hIobDGpboQ https://t.co/hIobDGpboQ
BMR:1